1.
CCR5 targeted SIV vaccination strategy preventing or inhibiting SIV infection
by Bogers, W.M.J.M
Vaccine, 2004, Vol.22 (23), p.2974-2984
2.
Enhancement of central nervous system pathology in early simian immunodeficiency virus infection by dopaminergic drugs
by CZUB, S
Acta neuropathologica, 2001, Vol.101 (2), p.85-91
3.
Decreased expression of IL-2 in central and effector CD4 memory cells during progression to AIDS in rhesus macaques
by KOOPMAN, Gerrit
AIDS (London), 2001, Vol.15 (18), p.2359-2369
4.
A clinically relevant HIV-1 subunit vaccine protects rhesus macaques from in vivo passaged simian-human immunodeficiency virus infection
by MOOIJ, P
AIDS (London), 1998, Vol.12 (5), p.F15-F22
5.
Inhibition of Apoptosis in T Cells Expressing Human T Cell Leukemia Virus Type I Tax
by Copeland, K. F
AIDS research and human retroviruses, 1994, Vol.10 (10), p.1259-1268
6.
A novel HIV-CCR5 receptor vaccine strategy in the control of mucosal SIV/HIV infection
by BOGERS, Willy M. J. M
AIDS (London), 2004, Vol.18 (1), p.25-36
7.
Rational development of prophylactic HIV vaccines based on structural and regulatory proteins
by Mooij, Petra
Vaccine, 2001, Vol.20 (3), p.304-321
8.
9.
Intact CCR-5 coreceptors in HIV-1-infected chimpanzees
by ten Haaft, P J.F
AIDS (London), 1997, Vol.11 (10), p.1291-1293
10.
Biological and pathological consequences of feline infectious peritonitis virus infection in the cheetah
by Evermann, J F
Archives of virology, 1988, Vol.102 (3-4), p.155-171
11.
Protection from HIV-1 envelope-bearing chimeric simian immunodeficiency virus (SHIV) in rhesus macaques infected with attenuated SIV : consequences of challenge
by BOGERS, W. M. J. M
AIDS (London), 1995, Vol.9 (12), p.F13-F18
12.
The Relative Resistance of HIV Type 1-Infected Chimpanzees to AIDS Correlates with the Maintenance of Follicular Architecture and the Absence of Infiltration by CD8+ Cytotoxic T Ly...
by Koopman, Gerrit
AIDS research and human retroviruses, 1999, Vol.15 (4), p.365-373
13.
Protection of rhesus macaques from SIV infection by immunization with different experimental SIV vaccines
by de Vries, Petra
Vaccine, 1994, Vol.12 (15), p.1443-1452
14.
Vaccine protection and reduced virus load from heterologous macaque-propagated SIV challenge
by HEENEY, J. L
AIDS research and human retroviruses, 1994, Vol.10, p.S117-S121
15.
Stimulation of both humoral and cellular immune responses to HIV-1 gp120 by interleukin-12 in Rhesus macaques
by van der Meide, Peter H
Vaccine, 2002, Vol.20 (17), p.2296-2302
16.
Antigenicity and immunogenicity of recombinant envelope glycoproteins of SIVmac32H with different in vivo passage histories
by Hulskotte, Ellen G.J
Vaccine, 1995, Vol.13 (13), p.1187-1197
17.
European contribution to the science, prevention and management of HIV infection
by Lehner, T
Vaccine, 1997, Vol.15 (5), p.465-468
18.
Vaccines and immunology. Recent advances in HIV/AIDS vaccine development
by Landay, A
AIDS (London), 2001, Vol.15 Suppl 5, p.S101-S103
19.
Vaccines and immunology: elucidating immunity to HIV-1 and current prospects for AIDS vaccine development
by Heeney, J L
AIDS (London), 2000, Vol.14 Suppl 3, p.S125-S127
20.
Safety and immunogenicity of ALVAC wild-type human p53 (vCP207) by the intravenous route in rhesus macaques
by Rosenwirth, Brigitte
Vaccine, 2001, Vol.19 (13), p.1661-1670
